Valiloxybate
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 29, 2020 (NCT04688580)
Timeline
Indications
Mechanism of action
- GABA-B receptor 1AGONIST
GABBR1 agonist
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)[C@H](N)C(=O)OCCCC(=O)O- Mol. weight
- 203.24 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095201 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05056194 | Phase 2 | Nov 1, 2021 | XWPharma |
| NCT04688580 | Early Phase 1 (Phase 1) | Nov 29, 2020 | XWPharma |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| XWPharma | For profit | 2 | 2 | 2 | 2020 |
1 organizations
Page 1 / 1